Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
MG-132 for Reliable Cell Assays
2026-08-11
A scenario-based guide to using MG-132, SKU A2585, in viability, apoptosis, cell-cycle, and oxidative-stress workflows. It distinguishes biochemical potency from cell-line-specific responses and provides practical guidance for stock preparation, controls, interpretation, and vendor selection.
-
How HIV-1 Remodels Nuclear Pores to Infect Resting T Cells
2026-08-11
The reference study identifies nuclear pore complex (NPC) passage as a major barrier to HIV-1 infection of resting CD4+ T cells and shows how cell–cell spread overcomes it. HIV-1 engages CD4–LCK signalling during virological synapse formation, activates CDK1 without requiring cell-cycle entry, and remodels nucleoporins to promote capsid nuclear import.
-
Palmitic acid: Protocol and QC Guide
2026-08-10
Palmitic acid (hexadecanoic acid, SKU N2456) supports controlled in vitro studies of lipid metabolism, protein palmitoylation, and related metabolic or inflammatory workflows. It is poorly suited to aqueous preparation or long-term solution storage, so solvent selection, vehicle controls, and prompt use are essential.
-
Palmitic acid: Handling and Assay Workflow Guide
2026-08-09
Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid for lipid metabolism, signaling, and metabolic disorder workflows. It is unsuitable for aqueous stock preparation or long-term solution storage, so solvent selection, reconstitution, vehicle controls, and prompt use are central to reproducibility.
-
Annexin V-PE Apoptosis Detection Kit
2026-08-08
The Annexin V-PE Apoptosis Detection Kit provides rapid apoptosis detection in live cells through phosphatidylserine externalization. This article presents an inflammation-aware assay strategy, showing how Annexin V-PE can separate immune activation from genuine cell-death responses in LPS and pentoxifylline research.
-
Canagliflozin Workflows for Renal Mitochondria
2026-08-07
Canagliflozin is more than a glucose-lowering tool: it enables integrated studies of renal glucose handling, proximal-tubule mitochondrial remodeling, and metabolic resilience. This workflow guide translates recent hypertensive–diabetic mouse findings into practical assay design, controls, and troubleshooting strategies.
-
Ceruletide in Pancreatic Function Research: Protocols & Pitf
2026-08-07
Ceruletide (caerulein) enables reproducible, high-fidelity modeling of pancreatic fibrosis and gastrointestinal disorders, making it indispensable for both foundational and translational research. This comprehensive guide distills the latest protocol enhancements, troubleshooting strategies, and actionable insights—grounded in recent mechanistic breakthroughs—for maximizing the value of Ceruletide in digestive disease studies.
-
Pioglitazone (SKU B2117): Reliable PPARγ Agonist for Lab Ass
2026-08-06
This article delivers a scenario-driven, evidence-based guide to applying Pioglitazone (SKU B2117) in cell viability, proliferation, and cytotoxicity assays. Drawing from validated protocols and recent literature, it addresses common experimental pitfalls and demonstrates how APExBIO’s Pioglitazone enhances reproducibility and biological insight in metabolic and inflammatory research.
-
CHIR 99021 Trihydrochloride: GSK-3 Inhibitor for Organoid Co
2026-08-06
CHIR 99021 trihydrochloride is a potent, selective GSK-3 inhibitor that enables tunable modulation of stem cell self-renewal and differentiation. Its nanomolar potency and solubility profile make it a preferred tool in insulin signaling pathway research and organoid modeling. Recent evidence demonstrates its critical role in achieving balanced cellular proliferation and diversity in human intestinal organoids.
-
Presynaptic α2-Adrenergic Modulation of Equine Airway Contra
2026-08-05
This study dissects the presynaptic role of α2-adrenergic receptor signaling in regulating cholinergic contractions within equine distal airways. By using Tolazoline to antagonize α2-adrenergic receptors, the authors clarify the mechanism underlying adrenergic modulation of airway smooth muscle tone—offering a refined model for in vitro airway neurophysiology.
-
Amplex Red Enables Precision Reactive Oxygen Species Detecti
2026-08-05
Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) delivers ultrasensitive, interference-resistant hydrogen peroxide detection, elevating confidence in oxidative stress and redox signaling assays. Its robust performance and adaptability empower both standard and advanced workflows, with proven value in dissecting complex cell signaling—such as iron-catalyzed pathways in airway inflammation.
-
Chloroquine (BA1002): Actionable Guide for Laboratory Resear
2026-08-04
Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) is a versatile research compound widely applied as an anti-inflammatory agent for malaria and rheumatoid arthritis models, as well as an autophagy inhibitor. This guide details practical usage boundaries, solubility constraints, and protocol parameters to optimize reproducibility in research workflows. It should not be used in aqueous assay systems or without careful monitoring of cytotoxicity and solubility limits.
-
Discovery and Characterization of MK 0893 as a Novel Glucago
2026-08-04
This article examines the development and characterization of MK 0893, a potent, selective, and orally bioavailable glucagon receptor antagonist. The reference study details its molecular optimization, mechanism of action, and efficacy in preclinical models of type 2 diabetes, providing a foundation for translational research into glucose modulation.
-
Exendin-4: Mechanistic Gateways and Strategic Leverage in Tr
2026-08-03
This thought-leadership article explores the mechanistic, experimental, and translational impact of Exendin-4 (Exenatide) as a GLP-1 receptor agonist, focusing on its role in insulin sensitivity improvement, hepatic steatosis reversal, and beta cell function research. Drawing on recent scientific advances, particularly the stable expression of Exendin-4 in Saccharomyces cerevisiae, we examine how next-generation workflows and validated reagents from APExBIO are reshaping the accessibility and reproducibility of type 2 diabetes research. The discussion bridges mechanistic insights with strategic guidance, offering actionable perspectives for translational researchers aiming to optimize their models and extend the reach of diabetes therapeutics.
-
CHIR 99021 trihydrochloride: Reliable GSK-3 Inhibitor for St
2026-08-03
This article addresses common challenges in cell viability and organoid culture workflows, demonstrating how CHIR 99021 trihydrochloride (SKU B5779) from APExBIO provides reproducible, high-sensitivity solutions for GSK-3 inhibition. By grounding recommendations in recent literature and real-world lab scenarios, researchers can optimize proliferation, differentiation, and assay reliability with confidence.